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Dear Readers, 
On behalf of the Co-Editor and the Editorial and 
Advisory Boards, I am pleased to introduce the first 
issue of Clinical Microbiology and Infection (CMI). 
Unlike the previous Journal of the European 
Society for Clinical Microbiology and Infectious 
Diseases, CMI will be automatically distributed to all 
members of ESCMID. 
Our goal is to have a journal which can offer high 
quality articles and reviews, educational material as well 
as sections in which readers are invited to express their 
interests (comments, letters, special articles . . .). 
The field of infectious diseases and clinical 
microbiology being larger than ever, I am fully aware 
of the danger of heterogeneity for a Journal widely 
open to the interests of the Members of a large Society 
such as ours. We wish to find the correct balance 
between publishing on a fascinating but diverse 
collection of topics and displaying a certain restraint to 
avoid becoming eclectic. Your contribution will be 
essential, especially now, to help the editorial policy 
evolve in the right direction and address your needs. 
A diversity in the Original Articles (10-12 per 
issue) will be maintained, provided their quality 
meets high standards, and substantial clinical studies will 
be welcome in this category. However, simple case 
reports will be discouraged unless they raise important 
questions requiring discussion and answers. Such case 
reports will be included as Letters to the Editors. 
Reviews and Continuing Education articles will 
address selected topics. We invite ESCMID and Board 
Members to offer suggestions for topics which will then 
be discussed at the annual meeting of the Editorial 
Board. 
As you will see, and as we already have made 
known in several presentations of CMI in ESCMID 
News, the European involvement of our Journal is of 
prime importance. A European view of epidemio- 
logical problems will be written in Epidemiological 
News in each issue by J.-C. Desenclos. In addition, 
A. E. Baert’s agreement to join our Editorial Board 
is a mark of the European Community’s interest in 
working towards better communication between Euro- 
pean scientists and promoting continuing education. 
CMI will publish supplements to the regular issues. 
European study groups and working parties, sym- 
posium organizers, universities, health organizations, 
the pharmaceutical industry and others . . . are invited 
to propose and sponsor supplements for publication. 
As a final word, let me draw your attention to the 
fact that the first two issues of the Journal will be sent 
free to all members of ESCMID. Membership renewal 
for 1996 includes the Journal and would, therefore, be 
welcome as soon as possible. 
I look forward to your reactions and input after 
receiving the first issues of CMI. 
Thank you for the enthusiastic support I am sure 
you will bring to CMI, which represents an important 
commitment on the part of ESCMID. 
J. Acar 
